Numerous topics will be addressed at this year's Asembia Specialty Pharmacy Summit, held in-person in Las Vegas from May 2 through 5, including updates on cell and gene therapies and insights on the future of the industry.
Asembia’s 2022 Specialty Pharmacy Summit is scheduled to take place next week from May 2-5 in Las Vegas, Nevada, and will feature keynote speaker Scott Gottlieb, MD, former commissioner of the FDA and senior advisor at CMS.
Sessions and panels will include discussions on all things specialty pharmacy, including advancements in treatment therapies, market access strategies, and the pharmaceutical pipeline.
The organization’s last meeting was held in October 2021, postponed due to COVID-19, while next week’s gathering will see a return to the regular Spring timeslot.
Continuing education courses run the gamut of treatments for disease states, including opportunities to learn about managing atopic dermatitis in pediatric patients and a review for specialty pharmacists on management of idiopathic pulmonary fibrosis.
Featured sessions also include updates on popular topics such as the role of pharmacists in driving future biosimilar adoption and the importance of protecting patient data alongside the risks to national data security.
Policy discussions will focus on challenges navigating state regulations, a look at President Biden’s health agenda in an election year, and the passage of the 30-year anniversary of the Public Health Service (PHS) 340B program.
On the payer side, experts are slated to discuss the slow uptake of digital therapeutics while representatives from Amazon Pharmacy and Eli Lilly will present a session called “Bringing Ecommerce Insights to Pharmacy.”
Updates on cell and gene therapies will be provided along with legal considerations on specialty pharmacies engaging in different patient infusion models.
The agenda features several patient-centered discussions including one on overcoming social determinates of health via specialized teams, presented by representatives from Walgreens.
An additional session titled “Navigating the Pandemic With EUA Therapies,” will address issues raised by supply challenges, therapy indications and time constraints, while “Understanding the Use of Patient-Reported Outcomes in Improving Pharmacy Care,” will highlight CVS’ efforts to optimize its supply management practices through personalized digital engagement.
Pharmacy accreditation, shifts in sites of care, and value based contracting will also be discussed, along with insights on medication adherence and financial barriers that my lead to prescription abandonment.
The conference will take place at the Wynn & Encore hotel with over 5000 industry attendees expected at the in-person event.
Keep an eye on our Asembia conference page for live coverage from Las Vegas, starting May 2.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More